Short Interest in Ekso Bionics Holdings, Inc. (NASDAQ:EKSO) Grows By 40.0%

Ekso Bionics Holdings, Inc. (NASDAQ:EKSO) saw a significant increase in short interest in the month of November. As of November 30th, there was short interest totalling 121,500 shares, an increase of 40.0% from the November 15th total of 86,800 shares. Based on an average daily volume of 81,500 shares, the short-interest ratio is presently 1.5 days.

Ekso Bionics Price Performance

Ekso Bionics stock opened at $0.57 on Friday. The firm has a market cap of $12.47 million, a PE ratio of -0.87 and a beta of 1.43. The company has a debt-to-equity ratio of 0.28, a current ratio of 2.81 and a quick ratio of 2.14. The stock’s fifty day moving average price is $0.84 and its two-hundred day moving average price is $1.02. Ekso Bionics has a one year low of $0.50 and a one year high of $3.13.

Ekso Bionics (NASDAQ:EKSO) last released its earnings results on Monday, October 28th. The company reported ($0.10) earnings per share (EPS) for the quarter, missing the consensus estimate of ($0.08) by ($0.02). The company had revenue of $4.13 million for the quarter, compared to analyst estimates of $6.00 million. Ekso Bionics had a negative return on equity of 83.09% and a negative net margin of 62.95%. During the same period last year, the company posted ($0.24) earnings per share. As a group, research analysts expect that Ekso Bionics will post -0.48 EPS for the current fiscal year.

Analysts Set New Price Targets

Several research analysts have weighed in on EKSO shares. HC Wainwright lowered their price objective on Ekso Bionics from $10.00 to $9.00 and set a “buy” rating on the stock in a research report on Tuesday, October 29th. StockNews.com started coverage on shares of Ekso Bionics in a research report on Friday. They set a “hold” rating on the stock. Finally, Lake Street Capital dropped their price objective on shares of Ekso Bionics from $2.50 to $2.00 and set a “buy” rating for the company in a research note on Tuesday, October 29th.

Ekso Bionics Company Profile

Ekso Bionics Holdings, Inc designs, develops, sells, and rents exoskeleton products in the Americas, Germany, Poland, Europe, the Middle East, Africa, the Asia Pacific, and internationally. It operates in two segments, EksoHealth and EksoWorks. The EksoHealth segment designs, engineers, manufactures, and markets exoskeletons for applications in the medical markets.